<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04554758</url>
  </required_header>
  <id_info>
    <org_study_id>KOBESS-II trial</org_study_id>
    <nct_id>NCT04554758</nct_id>
  </id_info>
  <brief_title>Comparative Analysis Between Sleeve Gastrectomy and Roux-en Y Gastric Bypass in Bariatric Operation</brief_title>
  <official_title>Korean OBEsity Surgical Treatment Study(KOBESS-II) : Protocol of a Prospective Multicenter Cohort Study on Morbid Obesity Patients Undergoing Sleeve Gastrectomy Versus Roux-en Y Gastric Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inha University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Korean Center for Disease Control and Prevention</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Inha University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, double-arm, multi-center cohort study on obese patients, for laparoscopic sleeve&#xD;
      gastrectomy versus Roux-en Y gastric bypass&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is prospective cohort study. Total 400 obese patients will be enrolled(Sleeve&#xD;
      gastrectomy 200 patients, Roux-en-Y gastric bypass 200)&#xD;
&#xD;
      The principal investigator or another clinical investigator in charge will individually&#xD;
      inform the patients about the study, before operation at out patient clinic. At that time&#xD;
      patient is selected to either sleeve gastrectomy group or Roux-en-Y gastric bypass group. All&#xD;
      investigator report to clinical research center about patients BMI and operation method.&#xD;
&#xD;
      About 30-35 obesity patients will be enrolled according to their BMI status. Patients' BMI&#xD;
      status is classified into several parts by 2.5 gap started from 27.5.&#xD;
&#xD;
      All patients will undergo periodically anthropometry, laboratory tests, bioelectrical&#xD;
      impedance analysis, gastrofiberscopy, polysomnography and abdomen CT before and after&#xD;
      surgery.&#xD;
&#xD;
      Patients with hypertension will undergo echocardiography. Patients with polycystic ovary&#xD;
      syndrome will be checked hormonal study. Patients with type 2 diabetes mellitus will be&#xD;
      performed 75g oral glucose tolerance test test.&#xD;
&#xD;
      Surgical complication include wound morbidities, gastrointestinal leakage or fistula,&#xD;
      postoperative bleeding, intra-abdominal abscess, stricture , adhesive ileus, reflux&#xD;
      esophagitis, marginal ulceration, dumping syndrome and internal hernia.&#xD;
&#xD;
      Systemic complication which is not associated with the operation field include ling&#xD;
      morbidities, heart morbidities, urinary morbidities and others.&#xD;
&#xD;
      Hospital mortality is defined as postoperative death form any cause within 30 days after&#xD;
      operation.&#xD;
&#xD;
      All patients will be followed up post operative 1 month, 3 month, 6 month, 12 month, 18&#xD;
      month, 24 month.&#xD;
&#xD;
      All patients' liver tissue, visceral fat and subcutaneous fat will be harvested during&#xD;
      operation.&#xD;
&#xD;
      All patients' blood sample will be collected at out patient clinic visit. All patients' urine&#xD;
      and face will be collected at out patient clinic visit and will be analyzed to evaluate&#xD;
      microbial change throughout pre and post operation period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">August 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Comparative double arm study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Obesity Cure Success Rate</measure>
    <time_frame>Postoperative 1 year</time_frame>
    <description>Proportion of patients who reach BMI bellow 25</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body weight change rate</measure>
    <time_frame>Postoperative 1 year</time_frame>
    <description>Decreased body weight proportion compare to preoperative body weight</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Waist circumference change rate</measure>
    <time_frame>Postoperative 1 year</time_frame>
    <description>Decreased waist circumference change proportion compare to preoperative waist circumference</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of morbid disease remission or partial remission</measure>
    <time_frame>Postoperative 1 year, 2 year</time_frame>
    <description>Remission rate or partial remission rate of morbid disease related to obesity such as hypertension, type 2 diabetes mellitus, hyperlipidemia after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complication rate and mortality rate</measure>
    <time_frame>Within postoperative 30 days</time_frame>
    <description>Number of participants surgical complications associate with the surgical technique or the operation field Number of participants mortality after operation associated with surgical complication or underlying disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Micronutrient deficiency</measure>
    <time_frame>Postoperative 1 year, 2 year</time_frame>
    <description>Incidence of micronutrient deficiency rate such as vitamine, calcium, iron</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life improvement rate and degree-1</measure>
    <time_frame>Postoperative 1 year, 2 year</time_frame>
    <description>Patients rate and quantitative analysis of the improved life quality using several survey EQ-5D-3L(EuroQol-5D) consists of 5 dimensions(mobility, self-care, usual activities, pain/discomfort and anxiety/depression).&#xD;
Each of which is scored as no/some/extreme problems. The dimension scores are converted into health utility scores ranging form 0(death) to 1(perfect health)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life improvement rate and degree-2</measure>
    <time_frame>Postoperative 1 year, 2 year</time_frame>
    <description>EQ-VAS(EuroQol-Visual Analogue scale) is a question scale ranging form 0 to 100.&#xD;
0 indicated the worst and 100 indicated the best condition. EQ-VAS provides important, complementary information on patient's view about their own health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life improvement rate and degree-3</measure>
    <time_frame>Postoperative 1 year, 2 year</time_frame>
    <description>Impact of Weight on QoL(IWQoL) has 5 dimensions and each dimension has several items.&#xD;
physical function : 11 items&#xD;
self-esteem : 7 items&#xD;
sexual life : 4 items&#xD;
public distress : 5 items&#xD;
work : 4 items&#xD;
Score range from 0 to 100 and 100 represents the best quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life improvement rate and degree-4</measure>
    <time_frame>Postoperative 1 year, 2 year</time_frame>
    <description>Moore-head-Ardelt QoL questionnaire II(MA-II) has 6 items(general self-esteem, physical activity, social contacts, satisfaction concerning work, pleasure related to sexuality and focus on eating behavior).&#xD;
All items are scored according to 10-level Likert scale(-0.5 to 0.5) and all have the same weight.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life improvement rate and degree-5</measure>
    <time_frame>Postoperative 1 year, 2 year</time_frame>
    <description>Obesity-related Psychosocial Problem scale(OP scale) consists of 8 items that measure the bothersome impact of body weight on given situations.&#xD;
(private gatherings in their own home, private gatherings at their friend or relative's home and going to restaurant)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Obesity, Morbid</condition>
  <condition>Overnutrition</condition>
  <condition>Nutrition Disorders</condition>
  <condition>Overweight and Obesity</condition>
  <condition>Body Weight Changes</condition>
  <arm_group>
    <arm_group_label>Sleeve gastrectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>200 obesity patients who undergo laparoscopic sleeve gastrectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Roux-en-Y gastric bypass</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>200 obesity patients who undergo laparoscopic Roux-en-Y gastric bypass</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sleeve gastrectomy</intervention_name>
    <description>Bariatric operation will be done by laparoscopic sleeve gastrectomy procedure.</description>
    <arm_group_label>Sleeve gastrectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Roux-en-Y gastric bypass</intervention_name>
    <description>Bariatric operation will be done by laparoscopic Roux-en-Y gastric bypass procedure.</description>
    <arm_group_label>Roux-en-Y gastric bypass</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  obesity patients(BMI over 35)&#xD;
&#xD;
          -  morbid obesity patients(BMI over 30) with cardiovascular disease, hypertension,&#xD;
             hyperlipidemia, type 2 diabetes mellitus, obstructive sleep apnea&#xD;
&#xD;
          -  type 2 diabetes mellitus obesity patients(BMI over 27.5) who were treated medical&#xD;
             therapy or HbA1C level over 7%&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who underwent previously bariatric operation&#xD;
&#xD;
          -  Patients who were diagnosed malignant disease patients within 5 years&#xD;
&#xD;
          -  Patients who were involved with other clinical trial within 3 months&#xD;
&#xD;
          -  Patients who are risky to conduct general anesthesia for operation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yoon Seok Heo, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inha University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Do Joong Park, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yong Suk Park, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seung Wan Ryu, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Keimyung University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Moon Won Yoo, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Ulsan univertisy Seoul Asan Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Han Hong Lee, Professor</last_name>
    <role>Study Director</role>
    <affiliation>The Catholic University of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ji Yeon Park, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Kyungpook National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sang Hyun Kim, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Soonchunhyang University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jong Won Kim, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Chung-Ang University Hopspital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jong Han Kim, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Korea University Medical Center(Guro Hospital)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>In Seob Lee, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Ulsan univertisy Seoul Asan Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>In Gyu Kwon, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Yonsei University Medical Center(Gangnam Hospital)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tae Kyung Ha, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Hanyang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sung Il Choi, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Kyung Hee University Hospital at Gangdong</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kyung Won Seo, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Kosin University Gospel Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yoon Seok Heo, Professor</last_name>
    <phone>+82-32-890-3437</phone>
    <email>gsheo@inha.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yun Suk Choi, Instructor</last_name>
    <phone>+82-32-890-3437</phone>
    <email>yunsukki@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Inha University Hospital</name>
      <address>
        <city>Incheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yoon Seok Heo, Professor</last_name>
      <phone>+82-32-890-3435</phone>
      <email>gsheo@inha.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 9, 2020</study_first_submitted>
  <study_first_submitted_qc>September 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 18, 2020</study_first_posted>
  <last_update_submitted>October 6, 2020</last_update_submitted>
  <last_update_submitted_qc>October 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inha University Hospital</investigator_affiliation>
    <investigator_full_name>Yoonseok Heo</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>primary bariatric surgery</keyword>
  <keyword>morbid obesity</keyword>
  <keyword>sleeve gastrectomy</keyword>
  <keyword>Roux-en Y gastric bypass</keyword>
  <keyword>South Korea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
    <mesh_term>Nutrition Disorders</mesh_term>
    <mesh_term>Overnutrition</mesh_term>
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Body Weight Changes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

